The US Food and Drug Administration has granted another approval for Johnson & Johnson's blockbuster Remicade, this time for the treatment of ulcerative colitis in paediatric patients who have had an ...

"For parents of children who suffer from the sometimes devastating effects of ulcerative colitis, the positive opinion adopted by the CHMP is encouraging news and a significant step towards making ...

PHILADELPHIA, PA, October 15, 2007- Clinical data presented today at the annual meeting of the American College of Gastroenterology (ACG) show that REMICADE significantly reduces the incidence of ...

BOSTON (MarketWatch) - The Food and Drug Administration has approved Johnson & Johnson's rheumatoid arthritis drug Remicade for the treatment of ulcerative colitis, a debilitating digestive disease.

"REMICADE has, for several years, demonstrated efficacy in the treatment of Crohn's disease, and now has proven its ability to be an effective therapy for patients with ulcerative colitis, for which ...

LONDON, Dec 17 (Reuters) - Britain's healthcare cost-effectiveness watchdog NICE said on Wednesday it had recommended the use of Remicade as an option for treating acute exacerbations of ulcerative ...

Please provide your email address to receive an email when new articles are posted on . Syversen and colleagues conducted a randomized, parallel-group, open label clinical rial of 411 patients with ...

BERLIN — Ulcerative colitis (UC) patients who fail on first-line therapy appear to have better outcomes with vedolizumab (Entyvio) than with infliximab, suggests EFFICACI, the first trial directly ...

The FDA has approved Remicade from Janssen Biotech to treat moderately to severely active ulcerative colitis in children over age 6 who responded inadequately to conventional therapy, according to an ...